Leerink Partners Assumes Contineum Therapeutics (CTNM) at Outperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| (NASDAQ: CTNM) | Delayed: 9.62 -0.07 (0.72%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $9.69 | 52 Week High | $ | |||
| Open | $10.00 | 52 Week Low | $ | |||
| Day High | $10.32 | P/E | N/A | |||
| Day Low | $9.57 | EPS | $ | |||
| Volume | 562,832 | |||||
